A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)

Kissei

Status and phase: Completed; Phase 3

Conditions: Anemia

Treatments: Drug: JR-131

Study type: Interventional

Funder types: Industry

Identifiers

NCT02912533

JR-131-302

Details and patient eligibility

About

The purpose of this study is to investigate the safety and efficacy for 52-week dosing of JR-131 in renal anemia patients with chronic kidney disease (CKD).

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients being treated with erythropoiesis stimulating agent.

Exclusion criteria

• Patients having complication or history of a cardiovascular / lung / brain infarction.
• Patients having a pronounced hemorrhagic lesion.

Trial design

0 participants in 1 patient group

JR-131

Experimental group

Treatment:

Drug: JR-131